Skip to main content
Allgens Medical Technology Co., Ltd. logo

Allgens Medical Technology Co., Ltd. — Investor Relations & Filings

Ticker · 688613 ISIN · CNE1000051W7 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2026-04-28 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688613

About Allgens Medical Technology Co., Ltd.

http://en.allgensmed.cn/

Allgens Medical Technology Co., Ltd. specializes in the research, development, and commercialization of advanced biomaterials and regenerative medical devices. The company focuses on tissue engineering solutions, particularly for orthopedics, dentistry, and neurosurgery. Its core product line features mineralized collagen bone graft substitutes, engineered to mimic the natural extracellular matrix of human bone to promote osteoconduction and integration. Allgens utilizes proprietary biomimetic technology to develop scaffolds that support cell attachment and tissue regeneration. The company’s portfolio includes clinical solutions for bone defect repair, spinal fusion, and maxillofacial reconstruction, providing high-performance alternatives to traditional grafting methods through innovative material science.

Recent filings

Filing Released Lang Actions
奥精医疗：关于公司非经营性资金占用及其他关联资金往来情况的专项报告
Audit Report / Information Classification · 95% confidence The document is a special report issued by an accounting firm (BDO China Shu Lun Pan Certified Public Accountants LLP) regarding non-operating fund occupation and other related party fund transactions for the fiscal year 2025 of 奥精医疗科技股份有限公司. It references an audit report issued on April 28, 2026, and includes detailed financial data tables about fund occupation and related party transactions. The document is a standalone audit-related report focusing on specific financial compliance and related party transactions, not a full annual report or interim report. It is not a mere announcement or certification but contains substantive audited financial information related to regulatory requirements. Therefore, it fits the category of an Audit Report / Information (AR). The document length is 4187 characters, which is consistent with a detailed audit report rather than a brief announcement or certification. Hence, the classification is AR with high confidence.
2026-04-28 Chinese
奥精医疗：关于2025年度“提质增效重回报”行动方案评估报告暨2026年度“提质增效重回报”行动方案的公告
Annual Report Classification · 95% confidence The document is an announcement by 奥精医疗科技股份有限公司 regarding the annual assessment report of their 2025 action plan and the 2026 action plan. It includes detailed descriptions of the company's business progress, R&D achievements, governance, investor relations, and dividend policy for 2025, as well as plans for 2026. The document contains substantive content about the company's yearly activities, financial and operational performance, and strategic outlook, which aligns with the characteristics of an Annual Report. The length (4947 characters) and detailed content indicate it is the report itself, not merely an announcement of a report. Therefore, the document fits the definition of an Annual Report (10-K).
2026-04-28 Chinese
奥精医疗：2025年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告及财务报表" which translates to "Audit Report and Financial Statements" for the fiscal year 2025. It includes detailed audit opinions from a certified public accounting firm (BDO China Shu Lun Pan Certified Public Accountants LLP), references to audit standards, and extensive financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes. The document contains actual financial data and detailed audit procedures, not just an announcement or certification. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. Therefore, this document fits the category of an Audit Report / Information (AR) rather than an Annual Report (10-K) or other categories.
2026-04-28 Chinese
战略与ESG委员会议事规则
Governance Information Classification · 95% confidence The document is titled "董事会战略与 ESG 委员会议事规则" which translates to "Board Strategic and ESG Committee Rules." It details the establishment, composition, responsibilities, decision-making procedures, meeting rules, and other governance aspects of the Board's Strategic and ESG Committee. The content focuses on internal governance structures, committee duties, and procedural rules rather than financial results, audit opinions, or shareholder meeting materials. There is no indication of financial data, audit reports, voting results, or announcements related to capital changes or legal proceedings. The document is a governance-related internal rules report, specifically about the board committee structure and ESG oversight. Therefore, it fits best under Governance Information (CGR). The document length is 3323 characters, which is sufficient for a detailed governance report and not a brief announcement or certification. Hence, the classification is CGR with high confidence.
2026-04-28 Chinese
奥精医疗：2025年度独立董事述职报告（赵凌云）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2025" from a company. It details the independent director's duties, attendance at board and shareholder meetings, communication with auditors, review of financial reports, and governance activities during the year 2025. It includes information about board composition, audit committee participation, internal control evaluations, and compliance with laws and regulations. The document is a detailed report on the independent director's annual duties and observations rather than a general annual report or financial statement. It is not a short announcement or certification but a substantive report on board/management information, specifically focusing on the independent director's role and activities. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (4222 characters) is sufficient for a detailed report but not a full annual report or interim report. No financial statements or earnings highlights are presented, so it is not an Annual Report (10-K) or Earnings Release (ER).
2026-04-28 Chinese
奥精医疗：2025年年度报告
Annual Report Classification · 100% confidence The document is titled "奥精医疗科技股份有限公司2025年年度报告" which translates to "Allgens Medical Technology Co., Ltd. 2025 Annual Report." It contains detailed financial data, management discussion and analysis, company overview, financial statements, audit report information, and other comprehensive disclosures typical of a full annual report. The document length is 15,000 characters, indicating a full report rather than a brief announcement. It includes audited financial statements, auditor's opinion, management's discussion, and detailed financial metrics for the fiscal year 2025. The presence of detailed sections such as "Management Discussion and Analysis," "Company Overview," and "Financial Report" confirms this is a full annual report. Therefore, the document should be classified as an Annual Report (10-K).
2026-04-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.